EXPERIENCE OF SCALP COOLING FOR PREVENTION CHEMOTHERAPY-INDUCED HAIR LOSS
Short-term results of using Orbis II Paxman device for prevention of chemotherapy-induced alopecia were analyzed. A total of 98 sessions of scalp cooling were performed in 32 patients. Twenty-four (80 %) scalpcooled patients had good hair preservation. The level of comfort during the procedure was...
Saved in:
| Main Authors: | I. S. Polezhaeva, Zh. A. Starceva, V. E. Goldberg, N. O. Popova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2017-06-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/522 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Efficacy of Paxman Scalp Cooling System in Preventing Hair Loss in Breast Cancer Patients Receiving Chemotherapy in Western India – Multi-centre Retrospective Cohort Study
by: Mangesh Mekha, et al.
Published: (2024-01-01) -
Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
by: Portia Lagmay-Fuentes, et al.
Published: (2024-07-01) -
Evaluation of Dermatoscopic (Trichoscopic) Patterns in Hair and Scalp Disorders: A Clinical Observational Study
by: Shantanu Kesharwani, et al.
Published: (2025-04-01) -
Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
by: Aleymi M. Perez, et al.
Published: (2024-09-01) -
Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances
by: Schaffrin-Nabe D, et al.
Published: (2025-06-01)